These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 22909197)
1. Genome-wide approaches in pharmacogenomics: heritability estimation and pharmacoethnicity as primary challenges. Gamazon ER; Perera M Pharmacogenomics; 2012 Jul; 13(10):1101-4. PubMed ID: 22909197 [No Abstract] [Full Text] [Related]
2. Genome-wide studies in pharmacogenomics: harnessing the power of extreme phenotypes. Gurwitz D; McLeod HL Pharmacogenomics; 2013 Mar; 14(4):337-9. PubMed ID: 23438876 [No Abstract] [Full Text] [Related]
3. Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity. Chan SL; Jin S; Loh M; Brunham LR Pharmacogenomics; 2015; 16(10):1161-78. PubMed ID: 25978008 [TBL] [Abstract][Full Text] [Related]
4. Ask the experts: pharmacogenomics and genome-wide association studies. Hakonarson H Pharmacogenomics; 2013 Mar; 14(4):365-8. PubMed ID: 23438883 [No Abstract] [Full Text] [Related]
5. Interview: a discussion on genome-wide associations in pharmacogenomics. Motsinger-Reif A Pharmacogenomics; 2013 Mar; 14(4):361-3. PubMed ID: 23438882 [No Abstract] [Full Text] [Related]
6. Pharmacogenetics and pharmacogenomics: development, science, and translation. Weinshilboum RM; Wang L Annu Rev Genomics Hum Genet; 2006; 7():223-45. PubMed ID: 16948615 [TBL] [Abstract][Full Text] [Related]
7. Cancer pharmacogenomics: implications on ethnic diversity and drug response. Patel JN Pharmacogenet Genomics; 2015 May; 25(5):223-30. PubMed ID: 25751395 [TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics: a systems approach. Wang L Wiley Interdiscip Rev Syst Biol Med; 2010; 2(1):3-22. PubMed ID: 20836007 [TBL] [Abstract][Full Text] [Related]
10. Methods for analysis in pharmacogenomics: lessons from the Pharmacogenetics Research Network Analysis Group. Srinivasan BS; Chen J; Cheng C; Conti D; Duan S; Fridley BL; Gu X; Haines JL; Jorgenson E; Kraja A; Lasky-Su J; Li L; Rodin A; Wang D; Province M; Ritchie MD Pharmacogenomics; 2009 Feb; 10(2):243-51. PubMed ID: 19207025 [TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics: historical perspective and current status. Charlab R; Zhang L Methods Mol Biol; 2013; 1015():3-22. PubMed ID: 23824846 [TBL] [Abstract][Full Text] [Related]
12. Copy number polymorphisms and anticancer pharmacogenomics. Gamazon ER; Huang RS; Dolan ME; Cox NJ Genome Biol; 2011; 12(5):R46. PubMed ID: 21609475 [TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics and pharmacogenetics. 1st Spanish Congress on Pharmacogenomics and Pharmacogenetics, January 23-25, 2005, Valencia, Spain. Iqbal O Pharmacogenomics; 2005 Apr; 6(3):205-7. PubMed ID: 16013951 [No Abstract] [Full Text] [Related]
14. Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy. O'Donnell PH; Dolan ME Clin Cancer Res; 2009 Aug; 15(15):4806-14. PubMed ID: 19622575 [TBL] [Abstract][Full Text] [Related]
15. Beyond the clinic: 'direct-to-consumer' genomic profiling services and pharmacogenomics. Prainsack B; Vayena E Pharmacogenomics; 2013 Mar; 14(4):403-12. PubMed ID: 23438887 [TBL] [Abstract][Full Text] [Related]
16. The relevance of "missing heritability " in pharmacogenomics. Sadee W Clin Pharmacol Ther; 2012 Oct; 92(4):428-30. PubMed ID: 22910439 [No Abstract] [Full Text] [Related]
17. Insights from genome-wide association studies of drug response. Zhou K; Pearson ER Annu Rev Pharmacol Toxicol; 2013; 53():299-310. PubMed ID: 23072379 [TBL] [Abstract][Full Text] [Related]
18. Personalized pharmacogenomics profiling using whole-genome sequencing. Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897 [TBL] [Abstract][Full Text] [Related]